|
JW stance on fibrin sealants
New advances in hemostasis include the use of Fibrin Sealants during select surgical procedures. While they have in the past had specific indications, one recently received a general hemostasis indication from the FDA. Given that development, I suspect they will continue to increase as a surgical option when the traditional means of stopping bleeds fail. This family of products contain either Bovine or Human components ( aprotinin, fibrinogen and thrombin) that are extracted from bovine and/or human donors.
Can someone explain the JW stance on receiving blood products, and would this include any and all products containg elements of blood from other human or animals? How about synthetic or recombinant products?
Just trying to learn about the JW stance on these issues....
|
You are currently accessing this Site as a guest. Please login or register by clicking Here
Linear Mode
